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Comment on the consensus report on the management of hyperglycaemia in Type 2 
diabetes by the American Diabetes Association and the European Association for the 
Study of Diabetes  
 
We read with interest the American Diabetes Association (ADA) and the European 
Association for the Study of Diabetes (EASD) joint consensus report on the management of 
hyperglycaemia in Type 2 diabetes [1].  Following publication of the report, discussions of 
the content among networks of behavioural and educational researchers prompted us to write 
this letter. 
This consensus report is to be commended for recommending that 'providers and 
health care systems should prioritize the delivery of patient-centered care'.  The report is also 
to be commended for providing some clear actions that can be taken to promote person-
centred care, including emphasizing the importance of diabetes self-management education 
and support, promoting shared decision-making between the person with diabetes and the 
healthcare professional, and pointing to some methods that may be beneficial in achieving 
this. At the same time, we also appreciate that there are challenges in implementing a person-
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centred approach and we would like to highlight and comment on some of the challenges we 
see in the Consensus Report. 
The first is that the report uses the term 'adherence' throughout, making the 
recommendation that 'Facilitating medication adherence should be specifically considered 
when selecting glucose-lowering medications'.  Whilst we agree that it is important to discuss 
the issues surrounding an individual’s willingness and ability to take any prescribed 
medications, we suggest that the word 'adherence' is used ill-advisedly in the report.   A 
recent series of position statements from Diabetes Australia [2], jointly by the ADA and 
American Association of Diabetes Educators [3] and jointly by Diabetes UK and the UK’s 
National Health Service [4], have pointed to the negative consequences of using the terms 
'adherence' and 'compliance', when talking with or about people living with diabetes. These 
position statements echo earlier commentaries that argue that compliance and adherence are 
dysfunctional concepts, and empirical work demonstrating that the assumptions underpinning 
these words are not substantiated [5].  The continued use of the term 'adherence', which 
implies an unequal relationship in which people with diabetes passively follow clinicians’ 
instructions, is at best unhelpful. The fact that diabetes care is largely stuck in this 'adherence' 
paradigm may explain why a series of Cochrane reviews on interventions to promote 
adherence have repeatedly concluded that 'Current methods of improving medication 
adherence for chronic health problems are mostly complex and not very effective' [6], and 
argued that the problem needs to be reconceptualized.  This can be done readily by active 
adoption of 'strengths-based, empowering language' [3] and of other recommendations in the 
above-mentioned position statements [2–4] to facilitate active engagement in self-care, health 
and well-being. 
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We are also concerned with the statement that 'effective consultations include 
motivational interviewing'. 'Motivational interviewing' is a specific set of intervention 
strategies and techniques requiring extensive training and significant time to 
deliver.  Consequently, it is not possible for most health professionals to include 
'motivational interviewing' in routine clinical and education practice. Furthermore, 
recommendations for integrating a specific set of tools and techniques into clinical practice 
require a high-quality evidence base;  however, this does not exist for motivational 
interviewing in diabetes or chronic disease care [7]. Whilst meta-analyses indicate a possible 
small benefit of such interventions, this is conflated with the additional time investment. We 
suggest that the emphasis needs to be placed not on specific methods but on the principles 
underpinning 'motivational interviewing', common to many effective psycho-educational 
interventions and essential to effective diabetes care. These principles move the clinician 
away from an 'adherence' paradigm, to focus not on persuading the person with diabetes to 
take a certain medication, but rather to raise awareness of the individual’s choices and enable 
agreement about which management option best fits the individual’s needs, goals, values and 
preferences.  
As part of the goal to individualize care, the Consensus Report also provides guidance 
on the assessment of 'key patient characteristics'; specifically, recommending assessment of 
'issues such as motivation and depression'. This seems at odds with ADA’s 2016 position 
statement on the psychosocial care of people with diabetes, which recommends considering 
an  'assessment of symptoms of diabetes distress, depression, anxiety, and disordered eating 
and of cognitive capacities' [8], and the ADA’s 2019 standards of diabetes care [9]. Thus, we 
are surprised that this joint consensus report does not specifically recommend assessment of 
diabetes distress, especially given a recent meta-analysis, which indicates that about one-third 
of individuals with Type 2 diabetes experience clinically significant levels of diabetes 
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distress [10]. We are also surprised that the report recommends the assessment of 'motivation', 
given that this term is vague, often used inappropriately, and is not easily assessed. We 
acknowledge that achieving a paradigm shift takes time, and requires persistent, consistent 
and insistent advocacy.  However, it is disappointing that this joint Consensus Report does 
not appear to be implementing the recent recommendations of the ADA, and other 
international bodies, to incorporate strengths-based language and related strategies, with the 
aim of enabling widespread promotion of truly person-centred diabetes care.   We we would 
therefore like to recommend that future similar endeavours (consensus reports, guidelines, 
position statements) include representation of a broader range of disciplines and relevant 
associations and study groups, e.g. the American Association of Diabetes Educators (AADE), 
the Psycho-Social Aspects of Diabetes Study (PSAD) group of the EASD, and the US-based 
Behavioral Research In Diabetes Group Exchange (BRIDGE). 
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